While Guardian Pharmacy Services Inc has overperformed by 2.51%, investors are advised to look at stock chart patterns for technical insight.
On October 21, 2024, Truist started tracking Guardian Pharmacy Services Inc (NYSE: GRDN) recommending Buy. A report published by Raymond James on October 21, 2024, Initiated its previous ‘Outperform’ rating for GRDN.
Analysis of Guardian Pharmacy Services Inc (GRDN)
Further, the quarter-over-quarter increase in sales is 33.59%, showing a positive trend in the upcoming months.
Guardian Pharmacy Services Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. Taking into account the quick ratio of the company, currently set at 0.77, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and GRDN has an average volume of 77.86K. On a monthly basis, the volatility of the stock is set at 7.65%, whereas on a weekly basis, it is put at 6.88%, with a gain of 10.80% over the past seven days. Furthermore, long-term investors anticipate a median target price of $25.00, showing growth from the present price of $24.11, which can serve as yet another indication of whether GRDN is worth investing in or should be passed over.
How Do You Analyze Guardian Pharmacy Services Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 64.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 15.24% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GRDN shares are owned by institutional investors to the tune of 15.24% at present.
